Effect of fennel extract on Anti-Müllerian Hormone and sonographic indices in infertile women with occult premature ovarian insufficiency: a randomized controlled clinical trial
Abstract
BACKGROUND: Premature Ovarian Insufficiency (POI) is a condition characterized by the inability to ovulate before the age of 40. The occult type of POI (OPOI) is associated with a significant decrease in fertility and normal FSH levels. Fennel (Foeniculum vulgare Mill.) is known for its antioxidant properties and potential benefits on ovarian function. This study aimed to determine the effect of fennel extract on Anti-Müllerian Hormone (AMH) levels and antral follicular count (AFC) in infertile women with occult premature ovarian insufficiency. METHODS: This randomized controlled clinical trial was conducted at Tabriz University of Medical Sciences. 60 Infertile women with OPOI were randomly assigned to either the intervention group, who received fennel extract, or the control group, who received a placebo, with a ratio of 1:1. AMH measurement and AFC were performed at baseline and after 60 days, on the third day of menstruation. RESULTS: AMH level and AFC at the baseline were not statistically significant between fennel and the placebo groups(p > 0.05). After the intervention, the difference in changes of AMH between the two groups was not statistically significant (p = 0.986). However, AFC in fennel group was significantly higher than the placebo group after intervention (mean difference = 1.6; confidence interval of 95%: from 0.07 to 3.1; p = 0.040). CONCLUSION: Fennel extract may have a beneficial effect on AFC in infertile women with occult POI, but had no effect on…
How strong is the evidence?
Evidence Hub reads this as a randomized trial, done in people. Its evidence level is 2 of 5 (High · randomized trial). Randomized trials of a reasonable size are the strongest single-study design. Reported size: 60 participants or records.
Read the paper
Related studies
- Tryptophan Metabolism and Gut-Brain Homeostasis
- Rationale for a Multi-Factorial Approach for the Reversal of Cognitive Decline in Alzheimer’s Disease and MCI: A Review
- Prioritized Research for the Prevention, Treatment, and Reversal of Chronic Disease: Recommendations From the Lifestyle Medicine Research Summit
- Relationship between sleep disorders and gut dysbiosis: what affects what?
- The role of CLOCK gene in psychiatric disorders: Evidence from human and animal research
- Genetic, Transcriptome, Proteomic, and Epidemiological Evidence for Blood-Brain Barrier Disruption and Polymicrobial Brain Invasion as Determinant Factors in Alzheimer’s Disease
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.